Real-world management of male patients with condylomata acuminata in Germany: A retrospective single-center case analysis

BackgroundCondylomata acuminata (genital warts) are one of the most common sexually transmitted infections, mainly caused by human papillomavirus types 6 and 11. While vaccination programs have reduced the incidence in young women since 2006, the healthcare situation for men in Germany remains poorly studied. The aim of this study was to analyse the reality of care for men with condylomata acuminata in both outpatient and inpatient settings.MethodsA retrospective analysis was conducted on 239 male patients treated for condylomata acuminata between 2020 and 2024 at the Department of Dermatology, Venerology and Allergology, University Medical Center Leipzig. The data collected encompassed demographic information, comorbidities including immune status and sexually transmitted infections, prior medical consultations, the type of treatment provided (outpatient or inpatient), where applicable duration of hospitalization, our therapeutic approach, and the overall recurrences rate.ResultsThe mean age of the patients was 41.1 years. 83.3% were treated on an outpatient basis, while 16.7% received inpatient or short-term inpatient care. The average length of stay for inpatients was 4.03 days (standard deviation: 2.75). Prior diagnostics were documented in 15.1% of cases. Overall recurrences occurred in 22.2% of patients. Only 7.5% had a documented HPV vaccination status.ConclusionsThese results highlight the significant disease burden of condylomata acuminata among men in Germany, with the majority of cases managed on an outpatient basis. The insufficient vaccination rate and low rates of prior diagnostics indicate deficits in prevention and structured care. Intensifying vaccination programs and optimizing treatment pathways could reduce the disease burden and the need for inpatient care.